HR Execs on the Move


 
At iA, we partner with our customers to transform pharmacy by deepening the patient-pharmacist relationship, enhancing patient safety and increasing operational efficiency.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.iarx.com
  • 711, Innovation Way
    Johnson City, NY USA 13790
  • Phone: 607.798.9376

Executives

Name Title Contact Details
Anthony Smith
Vice President of Sales Key Accounts Profile
Dave Ristow
Chief Financial Officer Profile
Adam McCauley
Chief Accounting Officer Profile

Similar Companies

Beth Israel Deaconess Hospital-Needham

BID Needham, part of Beth Israel Lahey Health, is focused on providing our patients with easy access to compassionate, safe and high-quality health care.

Summit Spine & Joint Centers

For compassionate and convenient care, Summit Spine & Joint Centers is the pain clinic you can trust. We provide treatment for a wide range of conditions. Call us today at (770) 962-3642.

Highfive Vet Wholesale

Automated purchasing for vet clinics | Less mundane tasks. More time for your mission.

Medizone International

Medizone International, Inc. is focused on commercializing the AsepticSure® System, a superior disinfectant technology compared to conventional systems or practices. The company developed the AsepticSure® System to combine oxidative compounds (O3 and H202) to produce a unique mixture of free radicals (H2O3 known as trioxidane) with much higher oxidative potential than ozone or hydrogen peroxide alone. After securing broad IP protection for the use of trioxidane for both healthcare and non-healthcare facility disinfecting systems and bioterrorism applications, Medizone released its AsepticSure® System for use in Canada, and several other global markets, through its expanding distributor network. The AsepticSure® System is EPA-approved, received the CE mark and is currently pursuing FDA 510(k) registration.

Monogram BioSciences

Monogram Biosciences, Inc. (Monogram) is a life sciences company committed to advancing personalized medicine and improving patient outcomes through the development of molecular diagnostic products that guide and target the appropriate treatments